CAS
GSK icon

Coppell Advisory Solutions’s GSK GSK Stock Holding History

Coppell Advisory Solutions’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-901
Closed -$30.6K – 954
2024
Q4 		$30.6K Sell
901
-184
-17% -$6.62K ﹤0.01% 733
2024
Q3 		$44.2K Buy
1,085
+20
+2% +$818 0.01% 590
2024
Q2 		$41K Buy
+1,065
New +$44.8K 0.01% 544
2023
Q4 		$68.7K Buy
+1,855
New +$66.6K 0.01% 431
2023
Q3 		– Sell
-27
Closed -$955 – 1325
2023
Q2 		$955 Buy
+27
New +$968 ﹤0.01% 1155

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Coppell Advisory Solutions's GSK Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of GSK (GSK) in Q1 2025, closing a stake of 901 shares — an estimated $30.6K sold.

Coppell Advisory Solutions first reported a position in GSK in Q2 2023 and held it in 5 quarters. The position peaked at $68.7K in Q4 2023. 857 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining GSK position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 901 GSK shares in Q1 2025, an estimated $30.6K.
  • Coppell Advisory Solutions first reported a position in GSK in Q2 2023 and held it in 5 quarters.
  • Coppell Advisory Solutions's GSK position peaked at $68.7K in Q4 2023.
  • 857 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.